You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Valmet: Reasonably priced
Valmet announced a huge 1 BNEUR deal in Brazil. In the interview analyst Antti Viljakainen explains what this means for the company. H2 guidance, valuation and recommendation are also discussed. NB! The interview was filmed on 10/2/2024.
00:00 Intro
00:11 Major deal in Brazil
02:49 Is the guidance reachable in H2?
04:18 Valuation & recommendation
Read our latest research on Valmet: The glass is half full
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
Vis alle videoer